The Agency will not ask for the following mandatory data elements for medicinal products by July 2012:
Location of the Pharmacovigilance System Master File
Description of packaging information
Regulated documents (Condition of marketing authorisation, Labelling and Package Leaflet).
In addition the highly controversial Structured Substance Information (SSI) is now optional. In terms of documents, only the SmPC will be required.